愛爾蘭苔（海葡萄／愛爾蘭海苔／鹿角菜） Sea Moss (Irish Moss) × 甲狀腺功能
結論：安全性檢視中
證據強度高度一致指向「淨傷害」而非「無效」：L2 PubMed 8 篇研究（含 1 篇 2026 cessation interventional + 1 篇 RCT Combet 2014 + 高品質綜述 Aakre 2021 + 多篇 Jod-Basedow 與 Wolff-Chaikoff 案例報告）證實海藻碘負荷可雙向破壞甲狀腺功能、停服後可逆，且機轉與劑量證據強健（碘含量物種內可達 10 倍變異、單匙乾粉可超過 UL 數倍）。
D 🔴 D 反證據 安全審查 ⚠️ medium — moderate promotional content
證據強度高度一致指向「淨傷害」而非「無效」：L2 PubMed 8 篇研究（含 1 篇 2026 cessation interventional + 1 篇 RCT Combet 2014 + 高品質綜述 Aakre 2021 + 多篇 Jod-Basedow 與 Wolff-Chaikoff 案例報告）證實海藻碘負荷可雙向破壞甲狀腺功能、停服後可逆，且機轉與劑量證據強健（碘含量物種內可達 10 倍變異、單匙乾粉可超過 UL 數倍）。
L5e ATA 直接將 carrageen／agar／kelp／seaweed 列入 Low-Iodine Diet 避免清單，等於同時雙重點名 sea moss（既為海藻、又為 carrageenan 與 agar 主要來源）；ATA + AACE 2012 hypothyroidism 指引明確「不建議」使用 kelp 或其他海藻基礎補充劑治療碘缺乏（含孕婦）。
L5c Cleveland Clinic 明確 contraindication「既有甲狀腺機能亢進或低下者勿用」、L5d Harvard 明確不背書補充用途、L5b Mayo 推論為 cautious-to-against。
L4b EFSA「against」健康宣稱、L4e WHO/ANSES「cautious」並明列禁忌族群、L5a NIH ODS 與 LactMed 直接引用 PMC8090171 Graves' patient Jod-Basedow 案例。
Sea moss 不是「無效」（C）而是「有反證據」+「有實際傷害訊號」+「主流學會明確反對」，符合 D 級錨點（多 MAs / 多學會顯示無效或有害）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.39
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
D · 安全審查
信心度
83%
證據方向一致性高
證據層級
E3
單篇高品質統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.392
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Iodine, Seaweed, and the Thyroid (Aakre I, Tveito Evensen L et al.; Eur Thyroid J)
結論：Seaweed is the most iodine-dense food source on Earth with extreme inter- and intra-species variability; brown seaweeds (kelp, kombu, wakame) regularly exceed tolerable upper limits even in single servings, while red algae including Chondrus crispus (Irish moss / sea moss) are 1-2 orders of magnitude lower but still highly variable. Review documents repeated case reports of seaweed-induced hyperthyroidism (Jod-Basedow) and hypothyroidism (failure to escape Wolff-Chaikoff). Authors recommend against unregulated seaweed supplements; salt iodization remains the preferred public-health route to iodine sufficiency.
前往 PubMed
Impact of habitual seaweed consumption on iodine nutrition and thyroid function: a non-randomized pre-post clinical study
結論：Habitual seaweed consumers had excessive iodine status (median UIC 270 mcg/L) and elevated TSH. Cessation of seaweed for 6 weeks significantly reduced median UIC to 87 mcg/L (p<0.001) and significantly decreased serum TSH, with the largest TSH improvements in highest-iodine consumers. Direct evidence that habitual seaweed intake suppresses thyroid function in a dose-dependent manner reversible on withdrawal.
前往 PubMed
Iodine Status and Thyroid Function in a Group of Seaweed Consumers in Norway (Aakre I et al.)
結論：All 44 seaweed consumers had excessive iodine status (UIC >300 mcg/L per WHO classification); median UIC 1200 mcg/L. TSH levels remained within reference range but were 'higher than in other comparable population groups,' indicating subclinical thyroid stress. Authors warn that absence of iodine labeling on seaweed products leaves consumers unaware of excess exposure and recommend consumer warnings.
前往 PubMed
Variability of iodine content in common commercially available edible seaweeds (Teas J et al.)
結論：Iodine content of commercial seaweeds spans >500-fold range; 'some Asian seaweed dishes may exceed the tolerable upper iodine intake level of 1,100 mcg/day.' Preharvest conditions (season, location, plant age) and post-harvest processing (sun-bleaching, granulation) substantially affect content. Establishes that label or product class is insufficient to predict iodine dose — direct laboratory testing of each batch is required.
前往 PubMed
Thyroid dysfunction following a kelp-containing marketed diet (Di Matola T et al.; BMJ Case Rep)
結論：Previously euthyroid 45-year-old woman developed Jod-Basedow hyperthyroidism within weeks of starting kelp-containing diet, then progressed to overt iodine-induced hypothyroidism ~2 months after diet cessation (failure to escape Wolff-Chaikoff). Required 3 months of levothyroxine to normalize. Concludes 'herbal medicine or diets for weight loss containing kelp should be avoided also in participants with no evidence of thyroid disease.'
前往 PubMed
Transient Hyperthyroidism following the ingestion of complementary medications containing kelp seaweed: A case-report (Picciotto D et al.)
結論：70-year-old woman with no prior thyroid disease developed transient hyperthyroidism (tachycardia, insomnia, anxiety, 6 kg weight loss in 3 months) after ingesting kelp tablets. Normal thyroid function regained after 3 months of antithyroid therapy plus withdrawal. Doppler ultrasound suggested Jod-Basedow phenomenon. Authors recommend that 'adults who consume complementary medication based on kelp seaweed should be informed of the risk of developing thyroid dysfunction also in the absence of any pre-existing thyroid disease.'
前往 PubMed
Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea (Mussig K et al.; J Gen Intern Med)
結論：39-year-old woman with multinodular goiter developed overt hyperthyroidism after 4 weeks of kelp tea. Recovery on antithyroid medication plus cessation. Authors conclude 'physicians should advise patients with underlying thyroid disease to avoid all complementary or alternative medications containing iodine,' establishing the heightened risk of Jod-Basedow in pre-existing nodular goiter.
前往 PubMed
Low-level seaweed supplementation improves iodine status in iodine-insufficient women (Combet E et al.; Br J Nutr)
結論：Two-week low-dose A. nodosum supplementation in iodine-insufficient women raised UIC from 78 to 140 mcg/L (p<0.001) — correcting mild deficiency — but simultaneously raised TSH from 1.5 to 2.1 mIU/L (p<0.001), with 2/42 participants exceeding normal TSH range, indicating early subclinical hypothyroidism even at moderate doses. Bioavailability 33% vs 59% for KI. Demonstrates that even 'low-level' seaweed dosing in deficient populations carries detectable thyroid risk.
前往 PubMed
L4a US FDA
謹慎
ANTICAKING AGENT OR FREE-FLOW AGENT, DRYING AGENT, EMULSIFIER OR EMULSIFIER SALT, FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT, FORMULATION AID, HUMECTANT, PROCESSING AID, STABILIZER OR THICKENER, TEXTURIZER 來源↗
L4b EU EFSA
反對
the consumption of seaweed can lead to a significantly increased exposure to metals, for which the intake from a diet without seaweed already exceeds the health-based guidance values. Furthermore, it can lead to high iodine intakes, which can lead to exceeding the established upper limit value. 來源↗
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
110 年 11 月 12 日衛授食字第 1101902563 號公告修正並自 112 年 1 月 1 日生效 §12012 鹿角菜膠 Carrageenan（食品添加物規格檢驗方法）；食用藻類及其製品應符合衛福部公告之食用藻類衛生標準，依紅藻、褐藻、綠藻及藍藻分類管制重金屬等污染物限量。 來源↗
L4e WHO
謹慎
the use of carrageenan in infant formula or formula for special medical purposes at concentrations up to 1000 mg/L is not of concern 來源↗
L5a NIH Office of Dietary Supplements
謹慎
Sea moss or Irish moss (Chondrus crispus) is a type of red seaweed that is used as food and medicine, although no medicinal value has been proven... Sea moss should be avoided during breastfeeding unless the levels of iodine and heavy metals have been shown to be low enough to be safe. 來源↗
L5b Mayo Clinic
謹慎
— 本適應症無對應資料
L5c Cleveland Clinic
謹慎
If you already have hyperthyroidism or hypothyroidism, don't take sea moss unless specifically advised by your healthcare provider. 來源↗
L5d Harvard Health
謹慎
Excessive intakes can sometimes lower the production of thyroid hormones and lead to a condition called hypothyroidism. ... Studies have found that regular intake of seaweed (several servings a week) can increase blood levels of thyroid stimulating hormone, which is a risk factor for hypothyroidism. ... Certain groups may be more sensitive to excessive iodine and should limit their intake of se… 來源↗
L5e Specialty Society (condition-mapped)
反對
The American Thyroid Association advises against the ingestion of iodine and kelp supplements containing in excess of 500 mcg iodine daily for children and adults and during pregnancy and lactation. Ingestion of greater than 1,100 mcg of iodine per day (Tolerable Upper Limit for iodine) is not recommended and may cause thyroid dysfunction. There is no known thyroid benefit of routine daily iodi… 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
台灣 PTT／Dcard／Mobile01／痞客邦 等社群幾乎無「愛爾蘭苔（sea moss）用於甲狀腺」的真實討論。零星出現的甲狀腺貼文與海苔貼文彼此無關（前者談甲亢就醫，後者談一般海苔熱量/酸鹼），未連結到 sea moss 補充品。中文語境中與「愛爾蘭苔」相關的內容幾乎全是 Amazon 美國的 sea moss 商品頁（Dr. Sebi 式歐美保健潮流的中譯行銷），尚未滲透台灣論壇；台灣的「海葡萄」多指台東/澎湖養殖的食用綠藻珍饈（命名重疊），非此補充品。屬冷門題材，缺乏在地社群共識，不予杜撰。
💬社群實感
無共識（台灣社群幾乎無相關真實使用經驗討論）
- 左旋甲狀腺素（Levothyroxine）替代治療
- 抗甲狀腺藥物（如 methimazole）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-thyroid-function-INT-sea-moss-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "愛爾蘭苔（海葡萄／愛爾蘭海苔／鹿角菜）能改善甲狀腺功能",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 1,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🔴 D 反證據"
}
}